Australian Clinical Labs
ACL.AX
#7286
Rank
NZ$0.64 B
Marketcap
$3.25
Share price
0.34%
Change (1 day)
17.75%
Change (1 year)

Operating Margin for Australian Clinical Labs (ACL.AX)

Operating Margin at the end of 2024: 5.27%

According to Australian Clinical Labs's latest financial reports and stock price the company's current Operating Margin is 5.27%. At the end of 2024 the company had an Operating Margin of 5.27%.

Operating Margin history for Australian Clinical Labs from 2021 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
20245.27%-24.46%
20236.98%-72.91%
202225.77%90.69%
202113.51%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.